CoreMap develops a proprietary electrophysiology mapping system that combines high-density electrical data acquisition with sophisticated analytical software to generate detailed electrical activation maps of atrial fibrillation. The platform is designed to help electrophysiologists identify arrhythmia sources more accurately during catheter ablation procedures. CoreMap plans to use the new capital to accelerate product development and move the technology closer to commercial availability. The company believes improved mapping can address persistent clinical challenges in AF treatment and support more targeted procedural decision-making. Founded in 2016 and headquartered in Burlington, Massachusetts, CoreMap is positioning itself to compete in the expanding electrophysiology market with strategic backing from Medtronic following the Series C financing.

Total raised

$78M

Funding rounds

8

Latest round

Series C

Latest activity

Jul 2026